Search clinical trials for: CLL, real-world evidence, acalabrutinib
Total 226 results
-
Fred Hutchinson Cancer CenterAstraZenecaRecruitingRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
Dana-Farber Cancer InstituteRecruitingRefractory Central Nervous System Lymphoma | Central Nervous System Lymphoma | Recurrent Central Nervous System LymphomaUnited States
-
Emory UniversityNational Cancer Institute (NCI); AstraZenecaRecruitingMantle Cell Lymphoma | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | Lymphoproliferative Disorder | Indolent Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States
-
Austin I KimAstraZeneca; Genentech, Inc.Recruiting
-
AstraZenecaRecruiting
-
National Health Research Institutes, TaiwanNational Taiwan University Hospital; China Medical University Hospital; Chang... and other collaboratorsNot yet recruitingPrimary Central Nervous System Lymphoma (PCNSL)
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingMantle Cell LymphomaUnited States
-
Sunnybrook Health Sciences CentreAstraZenecaRecruitingWaldenstrom MacroglobulinemiaCanada
-
Swiss Group for Clinical Cancer ResearchRecruitingDiffuse Large B-cell LymphomaSwitzerland, Italy
-
Massachusetts General HospitalGenentech, Inc.RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
University Hospital Southampton NHS Foundation...AstraZenecaRecruitingDiffuse Large B Cell LymphomaUnited Kingdom
-
UNC Lineberger Comprehensive Cancer CenterAstraZenecaRecruitingCentral Nervous System LymphomaUnited States
-
Stichting Hemato-Oncologie voor Volwassenen NederlandRecruitingCLL/SLLNetherlands, Belgium, Denmark
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Kartos Therapeutics, Inc.RecruitingChronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Diffuse Large B Cell LymphomaBelgium, Korea, Republic of, United States, United Kingdom, Italy, Switzerland, Australia, France, Poland, Portugal, Czechia
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
Washington University School of MedicineAstraZenecaRecruitingPrimary Central Nervous System LymphomaUnited States
-
University of WashingtonAstraZenecaRecruitingB-Cell Non-Hodgkin Lymphoma | Primary Mediastinal (Thymic) Large B-Cell Lymphoma | High Grade B-Cell Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Transformed Follicular Lymphoma to Diffuse...United States
-
Peking Union Medical College HospitalPeking University First Hospital; The First Affiliated Hospital of Anhui Medical... and other collaboratorsRecruiting
-
Fred Hutchinson Cancer CenterAstraZenecaRecruitingHematopoietic and Lymphoid Cell Neoplasm | Recurrent Moderate-Severe Chronic Graft Versus Host DiseaseUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMantle Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
University Health Network, TorontoBayer; AstraZeneca; Amgen; AnHeart Therapeutics Inc.; Applied Health Research Centre and other collaboratorsRecruitingCancer | Malignancies Multiple | Malignant Solid Tumor | Cancer, Therapy-Related | Molecular Sequence Variation | Genetic Alteration | Gene Fusion | Receptor Tyrosine Kinase Gene Mutation | RTK Family Gene Mutation | Ras (Kras or Nras) Gene MutationCanada
-
BeiGeneRecruitingWaldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUnited States
-
Shengjing HospitalThe People's Hospital of Liaoning Province; Liaoning Tumor Hospital & InstituteRecruiting
-
National Cancer Institute (NCI)RecruitingDiffuse Large B-Cell Lymphoma | Non-Hodgkin's Lymphoma | NHL | DLBCLUnited States
-
University of BirminghamAcerta Pharma, LLC; BloodwiseRecruitingRichter SyndromeUnited Kingdom
-
Rigshospitalet, DenmarkKarolinska Institutet; Academisch Medisch Centrum - Universiteit van Amsterdam... and other collaboratorsRecruitingCLLDenmark, Sweden, Netherlands
-
Duk-Woo Park, MDCardioVascular Research Foundation, KoreaRecruitingHeart Valve Diseases | Aortic Valve InsufficiencyKorea, Republic of, United States, China
-
Swedish Medical CenterAcerta Pharma BVRecruiting
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
MingSight Pharmaceuticals, IncRecruitingChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Aggressive LymphomaUnited States
-
M.D. Anderson Cancer CenterRecruitingChronic Lymphocytic LeukemiaUnited States
-
Acerta Pharma BVAstraZenecaActive, not recruitingLymphoma, Mantle CellUnited States, France, Italy, Taiwan, Mexico, Russian Federation, Vietnam, Belgium, Canada, Brazil, Hungary, Japan, Poland, China, Spain, Germany, Australia, Czechia, Korea, Republic of, Israel, Romania, Ukraine, Argentina, Peru, New Zealand and more
-
Laboratoire français de Fractionnement et de BiotechnologiesCompletedHemophiliaUnited States
-
AstraZenecaParexelActive, not recruitingAdvanced Haematological MalignanciesSpain, United States, Canada, Korea, Republic of, Poland, Australia, France, United Kingdom, Ireland
-
AstraZenecaActive, not recruiting
-
AstraZenecaActive, not recruitingPart1: Advanced B-cell Malignancies | Part2: r/rCLL and r/rMCL | Part3: Untreated CLLJapan
-
University of Massachusetts, WorcesterNational Heart, Lung, and Blood Institute (NHLBI)CompletedChildhood AsthmaUnited States
-
Acerta Pharma BVAstraZenecaActive, not recruitingChronic Lymphocytic LeukemiaUnited States, Spain, Canada, Italy, Taiwan, Russian Federation, Turkey, Germany, Korea, Republic of, Brazil, Hungary, Poland, China, Sweden, Bulgaria, Israel, United Kingdom, Australia, Saudi Arabia, Austria, France, Czechia, South... and more
-
AstraZenecaActive, not recruiting
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaUnited States, Italy, Spain, Belgium, Brazil, Poland, United Kingdom, Canada, Germany, Australia, Israel, Hungary, France, New Zealand, Chile, Lithuania, Sweden, Colombia
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingChronic Lymphocytic Leukemia | Autoimmune Hemolytic Anemia | Warm Antibody Autoimmune Hemolytic Anemia | Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUnited States
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaAustria, Italy, Spain, United Kingdom, Belgium, Taiwan, France, Korea, Republic of, Hungary, United States, Ukraine, Canada, Australia, Germany, Israel, Czechia, Russian Federation, Slovakia, Poland, Bulgaria, New Zealand, Sweden, C... and more
-
AstraZenecaActive, not recruitingUntreated Chronic Lymphocytic LeukemiaThailand, Vietnam, Philippines, China, Taiwan
-
Weill Medical College of Cornell UniversityAstraZeneca; Celgene CorporationActive, not recruitingMantle Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingMantle Cell LymphomaUnited States
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingLymphoma, Mantle-CellUnited States, China, Spain, Belgium, Canada, Australia, Czechia, Italy, Taiwan, Germany, Japan, New Zealand, United Kingdom, Denmark, Brazil, Israel, France, Netherlands, Korea, Republic of, Poland, Hungary, Austria, Switzerland, Por... and more
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaUnited States, Italy, Spain, United Kingdom, Belgium, Denmark, Hungary, Poland, Australia, Germany, Israel, Netherlands, Turkey, France, New Zealand